FindTrial
Sign In

A clinical study of precise typing and therapy for cervical dystonia

A clinical study of precise typing and therapy for cervical dystonia

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IOR-16009483
Enrollment
Unknown
Registered
2016-10-18
Start date
2016-11-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cervical dystonia

Interventions

Cohort 1:SPECT
Cohort 2:botulinum toxin

Sponsors

Shanghai Tongji Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. meet the diagnosis criteria of primary cervical dystonia; 2. symptoms last for at least 1 month; 3. did not receive surgery; 4. did not receive BTX therpy or more than 3 months from last treatment; 5. attained informed consent by the subjects.

Exclusion criteria

Exclusion criteria: 1. congenital torticollis, or caused by tumor,injury,drug et al; 2. primary cervical dystonia which only performed tremor; 3. unwilling to accept BTX therpy or had contraindication; 4. pregnant and lactating mothers; 5. mental disease.

Design outcomes

Primary

MeasureTime frame
TWSTRS scale;—

Countries

China

Contacts

Public ContactJin Lingjing

Department of Neurology, Shanghai Tongji Hospital, Tongji University School of Medicine

lingjingjin@163.com+86 15021312377

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026